Log in to save to my catalogue

ONECUT2 is a targetable master regulator of lethal prostate cancer that suppresses the androgen axis

ONECUT2 is a targetable master regulator of lethal prostate cancer that suppresses the androgen axis

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6614557

ONECUT2 is a targetable master regulator of lethal prostate cancer that suppresses the androgen axis

About this item

Full title

ONECUT2 is a targetable master regulator of lethal prostate cancer that suppresses the androgen axis

Publisher

New York: Nature Publishing Group US

Journal title

Nature medicine, 2018-12, Vol.24 (12), p.1887-1898

Language

English

Formats

Publication information

Publisher

New York: Nature Publishing Group US

More information

Scope and Contents

Contents

Treatment of prostate cancer (PC) by androgen suppression promotes the emergence of aggressive variants that are androgen receptor (AR) independent. Here we identify the transcription factor ONECUT2 (OC2) as a master regulator of AR networks in metastatic castration-resistant prostate cancer (mCRPC). OC2 acts as a survival factor in mCRPC models, s...

Alternative Titles

Full title

ONECUT2 is a targetable master regulator of lethal prostate cancer that suppresses the androgen axis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6614557

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6614557

Other Identifiers

ISSN

1078-8956

E-ISSN

1546-170X

DOI

10.1038/s41591-018-0241-1

How to access this item